Hydralazine, a traditional antihypertensive drug developed several decades ago, is well-known for its effect on lowering blood pressure; it directly reduces peripheral resistance by relaxing the smooth muscle cell layer in the arterial blood vessels. Additionally, hydralazine has also been used as an adjunct treatment for hypertension and chronic heart failure. This drug has also shown promising potential as a repurposing drug for atherosclerosis and other cardiovascular diseases through its antioxidative and anti-inflammatory properties. To help you gain more insights on hydralazine, join this webinar, where the eminent Interventional Cardiologist, Dr.
Dhiman Kahali , will share his insights on how hydralazine is transforming cardiovascular therapeutics on 16th Feb 2024, 8:00 pm onwards. Stay tuned! ##Reference## Chang TT, Chen JW. Potential Impacts of Hydralazine as a Novel…
